文献速递膀胱癌与上尿路尿路上皮癌

2020年肌层浸润性膀胱癌的前沿管理及未来展望

Cutting-edge Management of Muscle-invasive Bladder Cancer in 2020 and a Glimpse into the Future.
PubMed 文献 · Eur Urol Oncol · 2020-06-15

本文以一位63岁表现为肉眼血尿、经尿道切除诊断为肌层浸润性膀胱癌的患者为例,描述其接受新辅助化疗后行开放根治性膀胱切除加标准盆腔淋巴结清扫的临床过程,并从指南依从的现行标准治疗与基于近期科学进展的未来潜在策略两个视角,逐步阐述诊断与治疗选择。

要点

  • 肌层浸润性膀胱癌的标准治疗包括新辅助化疗后根治性膀胱切除加盆腔淋巴结清扫。
  • 病例展示应遵循指南推荐的标准治疗路径。
  • 未来治疗策略可能基于近期科学进展改变当前最优管理。

核心结论

  • 2020年肌层浸润性膀胱癌的标准治疗为新辅助化疗后开放根治性膀胱切除加标准盆腔淋巴结清扫。
  • 未来潜在治疗策略可能改变当前对膀胱癌最优管理的认识。

研究设计与样本

  • 基于病例的讨论,描述一位63岁男性肌层浸润性膀胱癌患者的临床过程。

主要发现

  • 患者因肉眼血尿就诊,经尿道切除诊断为肌层浸润性膀胱癌。
  • 计算机断层扫描显示局部晚期肿瘤。
  • 患者接受新辅助化疗后行开放根治性膀胱切除加标准盆腔淋巴结清扫。

临床怎么用

  • 临床应遵循指南依从的标准治疗路径管理肌层浸润性膀胱癌。
  • 同时关注基于近期科学进展的潜在额外或替代治疗方法的证据。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

This case-based discussion describes the clinical course of a 63-yr-old patient who presented with gross hematuria and was diagnosed with a muscle-invasive bladder cancer at transurethral resection. Computed tomography revealed a locally advanced tumor, and the patient underwent neoadjuvant chemotherapy followed by open radical cystectomy with standard pelvic lymph node dissection. In a step-by-step fashion, we elaborate on diagnostic and therapeutic treatment options from two different vantage points: (1) guideline-adherent treatment with the state-of-the-art standard of care, and (2) a glimpse into the future discussing the evidence of potential additional or alternative approaches based on recent scientific advances. PATIENT SUMMARY: In this case-based discussion, we follow the clinical course of a patient with advanced bladder cancer and elaborate how the state-of-the-art treatment looks like in 2020, based on the best available evidence. This is compared with potential future treatment strategies, which may change and alternate our understanding of optimal bladder cancer care.

来源:Eur Urol Oncol,查看原文。版权归原作者所有。

引用

  1. Vetterlein MW, Witjes JA, Loriot Y, et al. Cutting-edge Management of Muscle-invasive Bladder Cancer in 2020 and a Glimpse into the Future. Eur Urol Oncol. 2020. PMID: 32553706. doi:10.1016/j.euo.2020.06.001

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。